(EMAILWIRE.COM, June 30, 2020 ) The European Mammography Workstations Market is estimated to grow at a CAGR of 5.5% to reach USD 14 million by 2024 from USD 10 million in 2018.

Factors such as the rising burden of breast cancer, increasing market availability of multimodality diagnostic platforms, and the increasing patient awareness about the clinical benefits associated with the early diagnosis of breast conditions are driving the growth of the market.

Recent Developments:

- In February 2019, Fujifilm (Japan) launched ASPIRE Bellus II.

- In January 2018, Agfa-Gevaert NV (Belgium) signed a contract with the West Suffolk NHS Foundation Trust (UK) in order to implement enterprise imaging for radiology platform.

- In May 2017, Siemens AG (Germany) and Fraunhofer MEVIS (Germany) entered into a partnership for developing artificial intelligence software systems to facilitate diagnosis and therapy decisions in order to support physicians to define the best possible treatment approach.

Browse 39 market data Tables and 34 Figures spread through 115 Pages and in-depth TOC - Request Research Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=101392240

Market Segmentation in Detailed:

The multimodality mammography workstations segment accounted for the largest share of the European mammography workstations market, by modality, in 2018

On the basis of modality, the European mammography workstations market is segmented into mammography (X-ray) workstations and multimodality mammography workstations. In 2018, the multimodality mammography workstations segment accounted for the larger share of the European mammography workstations market. This can be attributed to the increasingly supportive government initiatives/regulations in Europe, increasing awareness about the diagnostic efficacy of contrast-enhanced digital mammography, growing market availability of integrated mammography solutions, techno-commercial advantages associated with multimodality mammography workstations, and the rising prevalence of breast cancer.

The breast care centers segment is expected to register the highest growth rate in the European mammography workstations market, by end user, during the forecast period

On the basis of end users, the European mammography workstations market is segmented into hospitals, surgical clinics, & diagnostic imaging centers; breast care centers; and researchers & academia. The breast care centers segment is projected to witness the highest growth rate in the European mammography workstations market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=101392240

Geographical Regions Mapped in Report:

This report covers the European mammography workstations market across Germany, the UK, France, Italy, Spain, and RoE. Germany accounted for the largest share of this market in 2018. The large share of Germany is primarily attributed to the better reimbursement scenario in the country as compared to other European countries, wider acceptance of multimodality mammography workstations among major end users (such as hospitals, surgical clinics, and breast care centers), and the rising patient demand for improved cancer screening.

Maior Key Players Mapped in Research Report:

General Electric (US), Koninklijke Philips N.V. (Netherlands), Hologic Inc. (US), Siemens (Germany), and FUJIFILM Corporation (Japan) are the major players in the European mammography workstations market. Other prominent players in this market include Carestream Health (US), EIZO Corporation (Japan), Agfa-Gevaert Group (Belgium), Barco (Belgium), Konica Minolta, Inc. (Japan), Benetec Advanced Medical Systems (Belgium), PLANMED OY (Finland), Sectra AB (Sweden), Aycan Medical Systems, LLC. (US), and Esaote SPA (Italy).